Late stage collaborations

Ferring’s approach to business development and alliance management translates into disciplined acquisitions and alliances that create or strengthen platforms for long-term growth, bringing worldwide innovative treatment options to our patients.

Our areas of focus are:

• Marketed products to leverage commercial infrastructure.
• Differentiated late-stage products to enhance our pipeline.
• Novel diagnostics, devices and technologies that complement our existing therapeutic areas.

Approachable and responsive, our business development team has a strong track record of acquisitions and licensing, and drive successful deals to maximize the value of our alliances. From development and regulatory activities, through to approval and efficient launches, the team is committed to ensuring that your product reaches patients worldwide and gets the attention it requires.